AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Ranbaxy ties up with Israeli Teva.

PTI - The Press Trust of India Ltd.

| December 20, 2004 | COPYRIGHT 2009 Asia Pulse Pty Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

Jerusalem, Dec 20 (PTI) India's largest pharmaceutical company, Ranbaxy Laboratories Ltd (RLL) wholly owned US subsidiary, Ranbaxy Pharmaceutical Inc (RPI), has reached an agreement with its Israeli counterpart, Teva Pharmaceutical Industries Ltd., under which the latter will commercially ship its 'Quinapril HCl' tablets.

The brand product has annual sales of approximately USD 555 million and doses of 5 mg, 10 mg, 20 mg and 40 mg will be marketed by Teva USA under the approval Ranbaxy recieved for the…

Related articles from newspapers, magazines, journals, and more
Teva Launches Quinapril HCl Tablets; Pursuant to Agreement with Ranbaxy.
Press release article from: Business Wire December 16, 2004 700+ words
...Teva has begun commercially shipping Quinapril HCl Tablets, 5 mg, 10 mg, 20 mg and...Teva label and marketed by Teva USA. Quinapril HCl Tablets are the AB-rated generic...period of marketing exclusivity for Quinapril HCl Tablets. In 2003, the FDA granted...
Teva launches Quinapril HCl tablets; pursuant to agreement with Ranbaxy.
News wire article from: Asia Africa Intelligence Wire December 16, 2004 700+ words
...Ltd has begun commercially shipping Quinapril HCl tablets 5 mg, 10 mg, 20 mg and 40...Teva label and marketed by Teva USA. Quinapril HCl tablets are the AB-rated generic...final approval for Teva's ANDA for Quinapril HCl tablets. As the first company to file...
Court of appeals upholds preliminary injunction against Ranbaxy, enjoining...
News wire article from: Chemical Business Newsbase November 22, 2005 700+ words
...Pharmaceuticals Inc (RPI) from marketing its Quinapril HCl Tablets (5, 10, 20, and 40 mg...Pfizer Inc, asserting that RPI's Quinapril HCl Tablets did not infringe on US Patent...Ranbaxy's non-infringement case. Quinapril HCl Tablets are the AB-rated generic...
Court of Appeals Upholds Preliminary Injunction Against Ranbaxy, Enjoining...
Press release article from: PR Newswire November 23, 2005 700+ words
...Pharmaceuticals Inc. (RPI) from marketing its Quinapril HCl Tablets (5, 10, 20, and 40 mg...Pfizer, Inc., asserting that RPI's Quinapril HCl Tablets did not infringe on U.S...Ranbaxy's non- infringement case. Quinapril HCl Tablets are the AB-rated generic...
Teva Pharmaceutical Industries Ltd.(Generics Notebook)(quinapril HCl tablets...
Magazine article from: Drug Store News January 17, 2005 700+ words
...Teva Pharmaceutical Industries Ltd. began shipment of its quinapril HCl tablets in 5 mg, 10 mg, 20 mg and 40 mg doses. The generic...will be sold under a Teva label and marketed by Teva USA. Quinapril HCl tablets are the AB-rated generic equivalent of Parke...
US COURT UPHOLDS PRELIMINARY INJUNCTION AGAINST RANBAXY FOR MARKETING QUINAPRIL...
Magazine article from: India Business Insight December 8, 2005 700+ words
...barring Ranbaxy Pharmaceuticals Inc (RPI) from marketing its Quinapril HCL tablets. Ranbaxy Laboratories Ltd (RLL) had appealed to...injunction. Pfizer Inc had filed a suit against RPI's Quinapril HCL tablets for infringing on its patented anti-hypertensive...
Teva Announces Tentative Approval for Quinapril HCL Tablets.
Press release article from: Business Wire February 11, 2002 700+ words
...Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration (FDA) has granted tentative approval for Quinapril HCL 5, 10, 20 and 40 mg tablets. This is the first tentative approval granted by FDA for Quinapril. Quinapril is the generic...
Israeli Teva purchased Ivaz Corp, controller of Laboratorio Chile.
News wire article from: The America's Intelligence Wire July 26, 2005 700+ words
(From Corporate Chile) Source: Diario Financiero The Israeli laboratory Teva Pharmaceutical, one of the worlds largest generic medicine producers, announced the purchase of its North American competitor Ivax through an operation worth US$7,400 million. The transaction is directly related to chile,
Ranbaxy of India to manufacture antihypertensive drug for Teva.
Newspaper article from: Economic Times (New Delhi, India) December 18, 2004 700+ words
...Pharmaceutical for antihypertensive drug Quinapril HCl tablets. Unlike the deal with Andrx...abbreviated new drug application (ANDA) for Quinapril HCl tablets has also got the final approval...under para IV filing for this drug. Quinapril HCl tablets are the AB-rated generic...
Ranbaxy signs deal with Israeli co Teva.
News wire article from: Asia Africa Intelligence Wire December 18, 2004 700+ words
...Pharmaceutical for antihypertensive drug Quinapril HCl tablets. Unlike the deal with Andrx...abbreviated new drug application (ANDA) for Quinapril HCl tablets has also got the final approval...under para IV filing for this drug. Quinapril HCl tablets are the AB-rated generic...
For more facts and information, see all results

Source: HighBeam Research, Ranbaxy ties up with Israeli Teva.

©2010 Gale, a part of Cengage Learning. All rights reserved. About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA

The AccessMyLibrary advertising network includes: womensforum.com GlamFamily